For this reason, an in vitro study that identified that CLL-1 is present on AML CD34+/CD38- cells but is not present on normal bone marrow CD34+/CD38- cells is an important find in terms of potential targets for AML [15]. This evidence concerns the gene CLEC12A and acute myeloid leukemia.